Skip to content
Hair Pipeline

How we track

We're not doctors

This site is run by someone who isn't a doctor, and no doctor reviews the pages before they go up. What we do is report what trial registries, regulators and published studies say, link every claim to its source, and check each page against those sources before publishing it. What we can't do is tell you whether a treatment is right for you, whether it is safe with your other medicines, or whether it is worth the risk for your kind of hair loss. That takes someone who can examine you. Before starting, stopping or changing any treatment, including the supplements and home remedies covered here, talk to a doctor or dermatologist.

Where the data comes from

Registered trials are pulled automatically every night from ClinicalTrials.gov (API v2). The programme register — which company is pursuing what, by which approach — is maintained by hand from peer-reviewed literature, regulatory filings and company disclosures.

What we verify by hand

A registered trial proves a sponsor declared a study. It does not prove the study is running, or that it will read out. Phase changes detected automatically are queued for review and only published once a human has confirmed them.

What we don't do

We don't rank treatments by expected efficacy, we don't predict launch dates, and we don't take payment to change a record. Programmes that fail stay in the register, marked discontinued — the history of failures is as informative as the history of successes.

Advertising and commercial links

Where we operate in the EU, Directive 2001/83/EC Article 88 prohibits direct-to-consumer advertising of prescription-only medicines, so we carry no commercial links to finasteride, dutasteride or any other prescription drug for European readers. Any paid link, when one exists, is disclosed on the page it appears on.

What "confidence" means

Every record shows a confidence level. It describes the quality of the source, not how sure we feel. High: confirmed by a trial registry, a regulatory document, or peer-reviewed publication. Medium: strongly supported, but by a secondary source — a sponsor's announcement not yet published, for instance. Low: inferred from the product name, the sponsor or a trial title, with nothing establishing it. Anything promoted out of the discovery queue starts at Low however plausible it looks, until a source is added.

Source hierarchy

The regulator's own document beats the press release reporting it; a peer-reviewed readout beats the sponsor's announcement of it. Where a claim rests only on a company release, the record says so. Every link is checked to resolve before it is published — two FDA URLs that looked canonical were already dead.

Update cadence

The trial import runs nightly. It can create a trial record and flag a phase change, but it can never publish one: a registered trial proves a sponsor filed paperwork, not that a programme advanced. Nothing an automated step produces is visible to a reader until a person has confirmed it.

Conflicts of interest

We take no funding from any sponsor listed, no payment for placement in the register, and no payment to add, change or remove a record. The site currently carries no advertising and earns no commission. If that changes it will be stated here and on the pages affected before the first euro is taken, not after.

Reporting an error

A wrong record on a health site does real harm. If you spot one, tell us — corrections are handled ahead of everything else.